Why the study?
Does (S,S)-1,2-bis(5-methoxy-2-benzimidazolyl)-1,2-ethanediol inhibit rhinovirus, poliovirus, and coxsackievirus infection in tissue culture systems?
Does (S,S)-1,2-bis(5-methoxy-2-benzimidazolyl)-1,2-ethanediol inhibit rhinovirus, poliovirus, and coxsackievirus infection in tissue culture systems?
bis-Benzimidazoles demonstrate potent prophylactic and therapeutic antiviral activity against rhinoviruses and other enteroviruses in vitro by inhibiting the formation of new infective virions.
Answers are grounded in this paper and cite their sources.
In vitro antiviral activity against enteroviruses supports further preclinical testing; leaves open clinical translation.
(S,S)-1,2-bis(5-methoxy-2-benzimidazolyl)-1,2-ethanediol showed antiviral activity in monolayer tissue culture systems against 55 strains of rhinovirus, three types of poliovirus, and strains of type A and B coxsackieviruses. Neither the compound nor any of the analogues tested showed virucidal activity. Its antiviral activity was not associated with interference with viral attachment to or penetration into the cell. At a concentration of 0.1 mg/ml, this group of compounds was generally nontoxic to WI-38, primary bovine kidney, and African green monkey kidney cells and had antiviral activity with 100% inhibition of virus-induced cytopathic effects (CPE). At antiviral levels, these compounds prevented CPE of up to 10(6) median tissue culture infective dose units of virus and completely inhibited formation of new infective virions. The compounds showed antiviral activity both prophylactically and therapeutically against rhinoviruses. Infected cultures could be cleared of CPE up to 90 hr after infection.
No takes yet. Share an insight, caveat, or question.
Schleicher et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: